NBP2-24729
antibody from Novus Biologicals
Targeting: TLR9
CD289
Antibody data
- Antibody Data
- Antigen structure
- References [135]
- Comments [0]
- Validations
- Western blot [3]
- Immunohistochemistry [2]
- Flow cytometry [10]
Submit
Validation data
Reference
Comment
Report error
- Product number
- NBP2-24729 - Provider product page
- Provider
- Novus Biologicals
- Product name
- Mouse Monoclonal TLR9 Antibody
- Antibody type
- Monoclonal
- Description
- Protein G purified.
- Reactivity
- Human, Mouse, Rat, Canine, Simian
- Host
- Mouse
- Isotype
- IgG
- Vial size
- 0.1 mg
- Concentration
- 1 mg/ml
- Storage
- Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Submitted references Hepatoma cell-intrinsic TLR9 activation induces immune escape through PD-L1 upregulation in hepatocellular carcinoma.
A proliferation-inducing ligand (APRIL) induced hyper-production of IgA from tonsillar mononuclear cells in patients with IgA nephropathy.
Necroptosis in pulmonary macrophages mediates lipopolysaccharide-induced lung inflammatory injury by activating ZBP-1.
Differential expression patterns of Toll Like Receptors and Interleukin-37 between calcific aortic and mitral valve cusps in humans.
Co-expression of TLR-9 and MMP-13 is associated with the degree of tumour differentiation in prostate cancer.
Toll-like receptors 2, 4 and 9 and hypoxia markers HIF-1alpha and CAIX in pancreatic intraepithelial neoplasia.
Elevated intragraft expression of innate immunity and cell death-related markers is a risk factor for adverse graft outcome.
Substance P represents a novel first-line defense mechanism in the nose.
Impaired Surface Expression of HLA-DR, TLR2, TLR4, and TLR9 in Ex Vivo-In Vitro Stimulated Monocytes from Severely Injured Trauma Patients.
Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans.
High-glucose induces tau hyperphosphorylation through activation of TLR9-P38MAPK pathway.
Tumor Location and Survival Outcomes in Adult Patients with Supratentorial Glioblastoma by Levels of Toll-Like Receptor 9 Expression.
Localization of nucleic acid-sensing toll-like receptors in human and mouse pancreas.
High toll-like receptor (TLR) 9 expression is associated with better prognosis in surgically treated pancreatic cancer patients.
Decreased Frequency of Intestinal Regulatory CD5+ B Cells in Colonic Inflammation.
Functional Toll-Like Receptor 9 Expression and CXCR3 Ligand Release in Pulmonary Sarcoidosis.
Cathepsin K expression is increased in oral lichen planus.
αv Integrins combine with LC3 and atg5 to regulate Toll-like receptor signalling in B cells.
Early IFN-γ production together with decreased expression of TLR3 and TLR9 characterizes EAE development conditional on the presence of myelin.
Pellino-1 confers chemoresistance in lung cancer cells by upregulating cIAP2 through Lys63-mediated polyubiquitination.
The proprotein convertase PC1/3 regulates TLR9 trafficking and the associated signaling pathways.
S1PR4 Signaling Attenuates ILT 7 Internalization To Limit IFN-α Production by Human Plasmacytoid Dendritic Cells.
Biopathological Significance of TLR9 Expression in Cancer Cells and Tumor Microenvironment Across Invasive Breast Carcinomas Subtypes.
The role of TLR9 in stress-dependent autophagy formation.
The Expression of Toll-like Receptors in Normal Human and Murine Gastrointestinal Organs and the Effect of Microbiome and Cancer.
TLR2 and TLR9 modulate enteric nervous system inflammatory responses to lipopolysaccharide.
Vaccination against canine leishmaniosis increases the phagocytic activity, nitric oxide production and expression of cell activation/migration molecules in neutrophils and monocytes.
Expression of Toll-like receptor -7 and -9 in B cell subsets from patients with primary Sjögren's syndrome.
Toll-like receptor 9 mediates invasion and predicts prognosis in squamous cell carcinoma of the mobile tongue.
TLR9 ligation in pancreatic stellate cells promotes tumorigenesis.
Members of the receptor for advanced glycation end products axis as potential therapeutic targets in patients with lupus nephritis.
Toll-like receptor 9 expression in the natural history of Barrett mucosa.
Heat shock protein 90 associates with Toll-like receptors 7/9 and mediates self-nucleic acid recognition in SLE.
Toll-like receptor 3 expression and function in childhood idiopathic nephrotic syndrome.
Deprived TLR9 expression in apparently healthy nasal mucosa might trigger polyp-growth in chronic rhinosinusitis patients.
Functional effects of Toll-like receptor (TLR)3, 7, 9, RIG-I and MDA-5 stimulation in nasal epithelial cells.
Activation of Toll-like receptor-9 promotes cellular migration via up-regulating MMP-2 expression in oral squamous cell carcinoma.
Recruitment of Cbl-b to B cell antigen receptor couples antigen recognition to Toll-like receptor 9 activation in late endosomes.
TLR9 and RIG-I signaling in human endocervical epithelial cells modulates inflammatory responses of macrophages and dendritic cells in vitro.
Expression of Toll-like receptor 9 increases with progression of cervical neoplasia in Tunisian women--a comparative analysis of condyloma, cervical intraepithelial neoplasia and invasive carcinoma.
Naïve T cells, unconventional NK and NKT cells, and highly responsive monocyte-derived macrophages characterize human cord blood.
Toll-like receptors and CD40 modulate each other's expression affecting Leishmania major infection.
TLR9 expressed on plasma membrane acts as a negative regulator of human B cell response.
The secretion of IL-6 by CpG-ODN-treated cancer cells promotes T-cell immune responses partly through the TLR-9/AP-1 pathway in oral squamous cell carcinoma.
Expression of TLR9 in tumor-infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer.
The role of TLR9 polymorphism in susceptibility to pulmonary tuberculosis.
Toll-like receptor 9 expression in mucoepidermoid salivary gland carcinoma may associate with good prognosis.
TLR2/1 and sphingosine 1-phosphate modulate inflammation, myofibroblast differentiation and cell migration in fibroblasts.
Characterization of the platelet granule proteome: evidence of the presence of MHC1 in alpha-granules.
Characterization of the Toll-like receptor expression profile in human multiple myeloma cells.
Expression of Toll-like receptor-9 is associated with poor progression-free survival in prostate cancer.
Expression of Toll-like receptor 9 in mouse and human lungs.
Expression of Toll-like receptors 2 and 9 in cells of dog jejunum and colon naturally infected with Leishmania infantum.
Short DNA sequences and bacterial DNA induce esophageal, gastric, and colorectal cancer cell invasion.
Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation.
Identification of lineage relationships and novel markers of blood and skin human dendritic cells.
Spontaneous production of immunoglobulin M in human epithelial cancer cells.
TLR4 and TLR9 are induced in oral lichen planus.
NK cell tolerance to TLR agonists mediated by regulatory T cells after polymicrobial sepsis.
The circadian clock controls toll-like receptor 9-mediated innate and adaptive immunity.
Campylobacter jejuni disrupts protective Toll-like receptor 9 signaling in colonic epithelial cells and increases the severity of dextran sulfate sodium-induced colitis in mice.
Molecular chaperoning by glucose-regulated protein 170 in the extracellular milieu promotes macrophage-mediated pathogen sensing and innate immunity.
Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma.
Increased Toll-like receptor 9 expression indicates adverse prognosis in oesophageal adenocarcinoma.
Engagement of TLR2 reverses the suppressor function of conjunctiva CD4+CD25+ regulatory T cells and promotes herpes simplex virus epitope-specific CD4+CD25- effector T cell responses.
Expression of Toll-like receptors 2 and 4 is increased in peripheral blood and synovial fluid monocytes of patients with enthesitis-related arthritis subtype of juvenile idiopathic arthritis.
Human papillomavirus deregulates the response of a cellular network comprising of chemotactic and proinflammatory genes.
Direct measurement of the quantum wavefunction.
Expression of toll-like receptor 9 in lungs of pigs, dogs and cattle.
Immunolocalization of pulmonary intravascular macrophages, TLR4, TLR9 and IL-8 in normal and Pasteurella multocida-infected lungs of water buffalo (Bubalus bubalis).
EBV lytic-phase protein BGLF5 contributes to TLR9 downregulation during productive infection.
TLR9-induced interferon β is associated with protection from gammaherpesvirus-induced exacerbation of lung fibrosis.
TLR9 signaling failure renders Peyer's patch regulatory B cells unresponsive to stimulation with CpG oligodeoxynucleotides.
CD14 is a coreceptor of Toll-like receptors 7 and 9.
Nasolacrimal duct closure modulates ocular mucosal and systemic CD4(+) T-cell responses induced following topical ocular or intranasal immunization.
Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific.
Protein kinase D1 is essential for the proinflammatory response induced by hypersensitivity pneumonitis-causing thermophilic actinomycetes Saccharopolyspora rectivirgula.
Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response.
Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors.
Chicken TLR21 is an innate CpG DNA receptor distinct from mammalian TLR9.
Expression of Toll-like receptor 9 in renal podocytes in childhood-onset active and inactive lupus nephritis.
TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients.
Toll-like receptor-9 expression is inversely correlated with estrogen receptor status in breast cancer.
Toll-like receptor expression in normal ovary and ovarian tumors.
Expression of toll-like receptor 9 in horse lungs.
Role for plasmacytoid dendritic cells in the immune control of recurrent human herpes simplex virus infection.
Pro-osteogenic phenotype of human aortic valve interstitial cells is associated with higher levels of Toll-like receptors 2 and 4 and enhanced expression of bone morphogenetic protein 2.
Stimulation of iNOS expression and apoptosis resistance in B-cell chronic lymphocytic leukemia (B-CLL) cells through engagement of Toll-like receptor 7 (TLR-7) and NF-kappaB activation.
STAT3- and STAT5-dependent pathways competitively regulate the pan-differentiation of CD34pos cells into tumor-competent dendritic cells.
Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion.
TLR9 is expressed in idiopathic interstitial pneumonia and its activation promotes in vitro myofibroblast differentiation.
Identification of two subpopulations of purified human blood B cells, CD27- CD23+ and CD27high CD80+, that strongly express cell surface Toll-like receptor 9 and secrete high levels of interleukin-6.
Expression of TLR9 within human glioblastoma.
Deoxynucleic acids from Cryptococcus neoformans activate myeloid dendritic cells via a TLR9-dependent pathway.
Deoxynucleic acids from Cryptococcus neoformans activate myeloid dendritic cells via a TLR9-dependent pathway.
Human lymphatic endothelial cells express multiple functional TLRs.
Human lymphatic endothelial cells express multiple functional TLRs.
Antibodies specific for human or murine Toll-like receptors detect canine leukocytes by flow cytometry.
Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus.
The toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells.
Localization of Toll-like receptors on epididymal epithelial cells and spermatozoa.
Inhibitors of TLR8 reduce TNF production from human rheumatoid synovial membrane cultures.
Inhibitors of TLR8 reduce TNF production from human rheumatoid synovial membrane cultures.
Induction of pro-inflammatory programs in enteroendocrine cells by the Toll-like receptor agonists flagellin and bacterial LPS.
Molecular cloning and characterization of equine Toll-like receptor 9.
CD300a/c regulate type I interferon and TNF-alpha secretion by human plasmacytoid dendritic cells stimulated with TLR7 and TLR9 ligands.
Toll-like receptors in the uterus, cervix, and placenta: is pregnancy an immunosuppressed state?
Surface expression of Toll-like receptor 9 is upregulated on intestinal epithelial cells in response to pathogenic bacterial DNA.
Nucleic acids exert a sequence-independent cooperative effect on sequence-dependent activation of Toll-like receptor 9.
Members of the Toll-like receptor family of innate immunity pattern-recognition receptors are abundant in the male rat reproductive tract.
Toll-like receptor 9 expression in murine and human adrenal glands and possible implications during inflammation.
Intracellular signaling mechanisms regulating toll-like receptor-mediated activation of eosinophils.
Molecular characterization of coding sequences and analysis of Toll-like receptor 3 mRNA expression in water buffalo (Bubalus bubalis) and nilgai (Boselaphus tragocamelus).
CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells.
EBV latent membrane protein 2A induces autoreactive B cell activation and TLR hypersensitivity.
EBV latent membrane protein 2A induces autoreactive B cell activation and TLR hypersensitivity.
Toll-like receptor 9 (TLR9) is present in murine liver sinusoidal endothelial cells (LSECs) and mediates the effect of CpG-oligonucleotides.
Novel toll-like receptor 9 agonist induces epidermal growth factor receptor (EGFR) inhibition and synergistic antitumor activity with EGFR inhibitors.
The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9.
Activation of anti-hepatitis C virus responses via Toll-like receptor 7.
Toll-like receptors in cellular subsets of human tonsil T cells: altered expression during recurrent tonsillitis.
Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome.
Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells.
Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-alpha.
Deoxycytidyl-deoxyguanosine oligonucleotide classes A, B, and C induce distinct cytokine gene expression patterns in rhesus monkey peripheral blood mononuclear cells and distinct alpha interferon responses in TLR9-expressing rhesus monkey plasmacytoid dendritic cells.
TGF-alpha regulates TLR expression and function on epidermal keratinocytes.
TGF-alpha regulates TLR expression and function on epidermal keratinocytes.
Expression of mRNA and proteins for toll-like receptors, associated molecules, defensins and LL-37 by SRIK-NKL, a CD8+ NK/T cell line.
Deviation from major codons in the Toll-like receptor genes is associated with low Toll-like receptor expression.
Human lung cancer cells express functionally active Toll-like receptor 9.
TLR-induced inflammation in cystic fibrosis and non-cystic fibrosis airway epithelial cells.
TLR-induced inflammation in cystic fibrosis and non-cystic fibrosis airway epithelial cells.
Evidence of Toll-like receptor molecules on human platelets.
Cytoplasmic domain-mediated dimerizations of toll-like receptor 4 observed by beta-lactamase enzyme fragment complementation.
CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides.
Zhou B, Yan J, Guo L, Zhang B, Liu S, Yu M, Chen Z, Zhang K, Zhang W, Li X, Xu Y, Xiao Y, Zhou J, Fan J, Hung MC, Li H, Ye Q
Theranostics 2020;10(14):6530-6543
Theranostics 2020;10(14):6530-6543
A proliferation-inducing ligand (APRIL) induced hyper-production of IgA from tonsillar mononuclear cells in patients with IgA nephropathy.
Takahara M, Nagato T, Nozaki Y, Kumai T, Katada A, Hayashi T, Harabuchi Y
Cellular immunology 2019 Jul;341:103925
Cellular immunology 2019 Jul;341:103925
Necroptosis in pulmonary macrophages mediates lipopolysaccharide-induced lung inflammatory injury by activating ZBP-1.
Du XK, Ge WY, Jing R, Pan LH
International immunopharmacology 2019 Dec;77:105944
International immunopharmacology 2019 Dec;77:105944
Differential expression patterns of Toll Like Receptors and Interleukin-37 between calcific aortic and mitral valve cusps in humans.
Kapelouzou A, Kontogiannis C, Tsilimigras DI, Georgiopoulos G, Kaklamanis L, Tsourelis L, Cokkinos DV
Cytokine 2019 Apr;116:150-160
Cytokine 2019 Apr;116:150-160
Co-expression of TLR-9 and MMP-13 is associated with the degree of tumour differentiation in prostate cancer.
Kalantari E, Abolhasani M, Roudi R, Farajollahi MM, Farhad S, Madjd Z, Askarian-Amiri S, Mohsenzadegan M
International journal of experimental pathology 2019 Apr;100(2):123-132
International journal of experimental pathology 2019 Apr;100(2):123-132
Toll-like receptors 2, 4 and 9 and hypoxia markers HIF-1alpha and CAIX in pancreatic intraepithelial neoplasia.
Leppänen J, Helminen O, Huhta H, Kauppila JH, Isohookana J, Haapasaari KM, Karihtala P, Parkkila S, Saarnio J, Lehenkari PP, Karttunen TJ
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2018 Nov;126(11):852-863
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2018 Nov;126(11):852-863
Elevated intragraft expression of innate immunity and cell death-related markers is a risk factor for adverse graft outcome.
Yang J, Snijders MLH, Haasnoot GW, van Kooten C, Mallat M, de Fijter JW, Clahsen-van Groningen MC, Claas FHJ, Eikmans M
Transplant immunology 2018 Jun;48:39-46
Transplant immunology 2018 Jun;48:39-46
Substance P represents a novel first-line defense mechanism in the nose.
Larsson O, Tengroth L, Xu Y, Uddman R, Kumlien Georén S, Cardell LO
The Journal of allergy and clinical immunology 2018 Jan;141(1):128-136.e3
The Journal of allergy and clinical immunology 2018 Jan;141(1):128-136.e3
Impaired Surface Expression of HLA-DR, TLR2, TLR4, and TLR9 in Ex Vivo-In Vitro Stimulated Monocytes from Severely Injured Trauma Patients.
Heftrig D, Sturm R, Oppermann E, Kontradowitz K, Jurida K, Schimunek L, Woschek M, Marzi I, Relja B
Mediators of inflammation 2017;2017:2608349
Mediators of inflammation 2017;2017:2608349
Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans.
Chandler MR, Keene KS, Tuomela JM, Forero-Torres A, Desmond R, Vuopala KS, Harris KW, Merner ND, Selander KS
PloS one 2017;12(9):e0183832
PloS one 2017;12(9):e0183832
High-glucose induces tau hyperphosphorylation through activation of TLR9-P38MAPK pathway.
Sun Y, Xiao Q, Luo C, Zhao Y, Pu D, Zhao K, Chen J, Wang M, Liao Z
Experimental cell research 2017 Oct 15;359(2):312-318
Experimental cell research 2017 Oct 15;359(2):312-318
Tumor Location and Survival Outcomes in Adult Patients with Supratentorial Glioblastoma by Levels of Toll-Like Receptor 9 Expression.
Mu L, Wang Y, Wang Y, Zhang H, Shang D, Tan F, Li Y, Chen X
World neurosurgery 2017 Jan;97:279-283
World neurosurgery 2017 Jan;97:279-283
Localization of nucleic acid-sensing toll-like receptors in human and mouse pancreas.
Helminen O, Huhta H, Kauppila JH, Lehenkari PP, Saarnio J, Karttunen TJ
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2017 Feb;125(2):85-92
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2017 Feb;125(2):85-92
High toll-like receptor (TLR) 9 expression is associated with better prognosis in surgically treated pancreatic cancer patients.
Leppänen J, Helminen O, Huhta H, Kauppila JH, Isohookana J, Haapasaari KM, Lehenkari P, Saarnio J, Karttunen TJ
Virchows Archiv : an international journal of pathology 2017 Apr;470(4):401-410
Virchows Archiv : an international journal of pathology 2017 Apr;470(4):401-410
Decreased Frequency of Intestinal Regulatory CD5+ B Cells in Colonic Inflammation.
Mishima Y, Ishihara S, Oka A, Fukuba N, Oshima N, Sonoyama H, Yamashita N, Tada Y, Kusunoki R, Moriyama I, Yuki T, Kawashima K, Kinoshita Y
PloS one 2016;11(1):e0146191
PloS one 2016;11(1):e0146191
Functional Toll-Like Receptor 9 Expression and CXCR3 Ligand Release in Pulmonary Sarcoidosis.
Schnerch J, Prasse A, Vlachakis D, Schuchardt KL, Pechkovsky DV, Goldmann T, Gaede KI, Müller-Quernheim J, Zissel G
American journal of respiratory cell and molecular biology 2016 Nov;55(5):749-757
American journal of respiratory cell and molecular biology 2016 Nov;55(5):749-757
Cathepsin K expression is increased in oral lichen planus.
Siponen M, Bitu CC, Al-Samadi A, Nieminen P, Salo T
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2016 Nov;45(10):758-765
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2016 Nov;45(10):758-765
αv Integrins combine with LC3 and atg5 to regulate Toll-like receptor signalling in B cells.
Acharya M, Sokolovska A, Tam JM, Conway KL, Stefani C, Raso F, Mukhopadhyay S, Feliu M, Paul E, Savill J, Hynes RO, Xavier RJ, Vyas JM, Stuart LM, Lacy-Hulbert A
Nature communications 2016 Mar 11;7:10917
Nature communications 2016 Mar 11;7:10917
Early IFN-γ production together with decreased expression of TLR3 and TLR9 characterizes EAE development conditional on the presence of myelin.
Evangelista MG, Castro SB, Alves CC, Dias AT, Souza VW, Reis LB, Silva LC, Castañon MC, Farias RE, Juliano MA, Ferreira AP
Autoimmunity 2016 Jun;49(4):258-67
Autoimmunity 2016 Jun;49(4):258-67
Pellino-1 confers chemoresistance in lung cancer cells by upregulating cIAP2 through Lys63-mediated polyubiquitination.
Jeon YK, Kim CK, Koh J, Chung DH, Ha GH
Oncotarget 2016 Jul 5;7(27):41811-41824
Oncotarget 2016 Jul 5;7(27):41811-41824
The proprotein convertase PC1/3 regulates TLR9 trafficking and the associated signaling pathways.
Duhamel M, Rodet F, Murgoci AN, Desjardins R, Gagnon H, Wisztorski M, Fournier I, Day R, Salzet M
Scientific reports 2016 Jan 18;6:19360
Scientific reports 2016 Jan 18;6:19360
S1PR4 Signaling Attenuates ILT 7 Internalization To Limit IFN-α Production by Human Plasmacytoid Dendritic Cells.
Dillmann C, Ringel C, Ringleb J, Mora J, Olesch C, Fink AF, Roberts E, Brüne B, Weigert A
Journal of immunology (Baltimore, Md. : 1950) 2016 Feb 15;196(4):1579-90
Journal of immunology (Baltimore, Md. : 1950) 2016 Feb 15;196(4):1579-90
Biopathological Significance of TLR9 Expression in Cancer Cells and Tumor Microenvironment Across Invasive Breast Carcinomas Subtypes.
Meseure D, Vacher S, Drak Alsibai K, Trassard M, Nicolas A, Leclere R, Lerebours F, Guinebretiere JM, Marangoni E, Lidereau R, Bieche I
Cancer microenvironment : official journal of the International Cancer Microenvironment Society 2016 Dec;9(2-3):107-118
Cancer microenvironment : official journal of the International Cancer Microenvironment Society 2016 Dec;9(2-3):107-118
The role of TLR9 in stress-dependent autophagy formation.
Lim JS, Kim HS, Nguyen KC, Cho KA
Biochemical and biophysical research communications 2016 Dec 9;481(3-4):219-226
Biochemical and biophysical research communications 2016 Dec 9;481(3-4):219-226
The Expression of Toll-like Receptors in Normal Human and Murine Gastrointestinal Organs and the Effect of Microbiome and Cancer.
Huhta H, Helminen O, Kauppila JH, Salo T, Porvari K, Saarnio J, Lehenkari PP, Karttunen TJ
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2016 Aug;64(8):470-82
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2016 Aug;64(8):470-82
TLR2 and TLR9 modulate enteric nervous system inflammatory responses to lipopolysaccharide.
Burgueño JF, Barba A, Eyre E, Romero C, Neunlist M, Fernández E
Journal of neuroinflammation 2016 Aug 18;13(1):187
Journal of neuroinflammation 2016 Aug 18;13(1):187
Vaccination against canine leishmaniosis increases the phagocytic activity, nitric oxide production and expression of cell activation/migration molecules in neutrophils and monocytes.
Moreira ML, Costa-Pereira C, Alves ML, Marteleto BH, Ribeiro VM, Peruhype-Magalhães V, Giunchetti RC, Martins-Filho OA, Araújo MS
Veterinary parasitology 2016 Apr 15;220:33-45
Veterinary parasitology 2016 Apr 15;220:33-45
Expression of Toll-like receptor -7 and -9 in B cell subsets from patients with primary Sjögren's syndrome.
Karlsen M, Hansen T, Nordal HH, Brun JG, Jonsson R, Appel S
PloS one 2015;10(3):e0120383
PloS one 2015;10(3):e0120383
Toll-like receptor 9 mediates invasion and predicts prognosis in squamous cell carcinoma of the mobile tongue.
Kauppila JH, Korvala J, Siirilä K, Manni M, Mäkinen LK, Hagström J, Atula T, Haglund C, Selander KS, Saarnio J, Karttunen TJ, Lehenkari PP, Salo T
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2015 Sep;44(8):571-7
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2015 Sep;44(8):571-7
TLR9 ligation in pancreatic stellate cells promotes tumorigenesis.
Zambirinis CP, Levie E, Nguy S, Avanzi A, Barilla R, Xu Y, Seifert L, Daley D, Greco SH, Deutsch M, Jonnadula S, Torres-Hernandez A, Tippens D, Pushalkar S, Eisenthal A, Saxena D, Ahn J, Hajdu C, Engle DD, Tuveson D, Miller G
The Journal of experimental medicine 2015 Nov 16;212(12):2077-94
The Journal of experimental medicine 2015 Nov 16;212(12):2077-94
Members of the receptor for advanced glycation end products axis as potential therapeutic targets in patients with lupus nephritis.
Yu SL, Wong CK, Szeto CC, Li EK, Cai Z, Tam LS
Lupus 2015 Jun;24(7):675-86
Lupus 2015 Jun;24(7):675-86
Toll-like receptor 9 expression in the natural history of Barrett mucosa.
Huhta H, Helminen O, Kauppila JH, Takala H, Metsikkö K, Lehenkari P, Saarnio J, Karttunen T
Virchows Archiv : an international journal of pathology 2015 Jul;467(1):9-18
Virchows Archiv : an international journal of pathology 2015 Jul;467(1):9-18
Heat shock protein 90 associates with Toll-like receptors 7/9 and mediates self-nucleic acid recognition in SLE.
Saito K, Kukita K, Kutomi G, Okuya K, Asanuma H, Tabeya T, Naishiro Y, Yamamoto M, Takahashi H, Torigoe T, Nakai A, Shinomura Y, Hirata K, Sato N, Tamura Y
European journal of immunology 2015 Jul;45(7):2028-41
European journal of immunology 2015 Jul;45(7):2028-41
Toll-like receptor 3 expression and function in childhood idiopathic nephrotic syndrome.
Jamin A, Dehoux L, Dossier C, Fila M, Heming N, Monteiro RC, Deschênes G
Clinical and experimental immunology 2015 Dec;182(3):332-45
Clinical and experimental immunology 2015 Dec;182(3):332-45
Deprived TLR9 expression in apparently healthy nasal mucosa might trigger polyp-growth in chronic rhinosinusitis patients.
Tengroth L, Arebro J, Kumlien Georén S, Winqvist O, Cardell LO
PloS one 2014;9(8):e105618
PloS one 2014;9(8):e105618
Functional effects of Toll-like receptor (TLR)3, 7, 9, RIG-I and MDA-5 stimulation in nasal epithelial cells.
Tengroth L, Millrud CR, Kvarnhammar AM, Kumlien Georén S, Latif L, Cardell LO
PloS one 2014;9(6):e98239
PloS one 2014;9(6):e98239
Activation of Toll-like receptor-9 promotes cellular migration via up-regulating MMP-2 expression in oral squamous cell carcinoma.
Ruan M, Zhang Z, Li S, Yan M, Liu S, Yang W, Wang L, Zhang C
PloS one 2014;9(3):e92748
PloS one 2014;9(3):e92748
Recruitment of Cbl-b to B cell antigen receptor couples antigen recognition to Toll-like receptor 9 activation in late endosomes.
Veselits M, Tanaka A, Lipkowitz S, O'Neill S, Sciammas R, Finnegan A, Zhang J, Clark MR
PloS one 2014;9(3):e89792
PloS one 2014;9(3):e89792
TLR9 and RIG-I signaling in human endocervical epithelial cells modulates inflammatory responses of macrophages and dendritic cells in vitro.
Sathe A, Reddy KV
PloS one 2014;9(1):e83882
PloS one 2014;9(1):e83882
Expression of Toll-like receptor 9 increases with progression of cervical neoplasia in Tunisian women--a comparative analysis of condyloma, cervical intraepithelial neoplasia and invasive carcinoma.
Fehri E, Ennaifer E, Ardhaoui M, Ouerhani K, Laassili T, Bel Haj Rhouma R, Guizani I, Boubaker S
Asian Pacific journal of cancer prevention : APJCP 2014;15(15):6145-50
Asian Pacific journal of cancer prevention : APJCP 2014;15(15):6145-50
Naïve T cells, unconventional NK and NKT cells, and highly responsive monocyte-derived macrophages characterize human cord blood.
López MC, Palmer BE, Lawrence DA
Immunobiology 2014 Oct;219(10):756-65
Immunobiology 2014 Oct;219(10):756-65
Toll-like receptors and CD40 modulate each other's expression affecting Leishmania major infection.
Chandel HS, Pandey SP, Shukla D, Lalsare K, Selvaraj SK, Jha MK, Saha B
Clinical and experimental immunology 2014 May;176(2):283-90
Clinical and experimental immunology 2014 May;176(2):283-90
TLR9 expressed on plasma membrane acts as a negative regulator of human B cell response.
Guerrier T, Pochard P, Lahiri A, Youinou P, Pers JO, Jamin C
Journal of autoimmunity 2014 Jun;51:23-9
Journal of autoimmunity 2014 Jun;51:23-9
The secretion of IL-6 by CpG-ODN-treated cancer cells promotes T-cell immune responses partly through the TLR-9/AP-1 pathway in oral squamous cell carcinoma.
Ruan M, Thorn K, Liu S, Li S, Yang W, Zhang C, Zhang C
International journal of oncology 2014 Jun;44(6):2103-10
International journal of oncology 2014 Jun;44(6):2103-10
Expression of TLR9 in tumor-infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer.
Belmont L, Rabbe N, Antoine M, Cathelin D, Guignabert C, Kurie J, Cadranel J, Wislez M
International journal of cancer 2014 Feb 15;134(4):765-77
International journal of cancer 2014 Feb 15;134(4):765-77
The role of TLR9 polymorphism in susceptibility to pulmonary tuberculosis.
Bharti D, Kumar A, Mahla RS, Kumar S, Ingle H, Shankar H, Joshi B, Raut AA, Kumar H
Immunogenetics 2014 Dec;66(12):675-81
Immunogenetics 2014 Dec;66(12):675-81
Toll-like receptor 9 expression in mucoepidermoid salivary gland carcinoma may associate with good prognosis.
Korvala J, Harjula T, Siirilä K, Almangush A, Aro K, Mäkitie AA, Grénman R, Karttunen TJ, Leivo I, Kauppila JH, Salo T
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2014 Aug;43(7):530-7
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2014 Aug;43(7):530-7
TLR2/1 and sphingosine 1-phosphate modulate inflammation, myofibroblast differentiation and cell migration in fibroblasts.
Hamidi S, Schäfer-Korting M, Weindl G
Biochimica et biophysica acta 2014 Apr 4;1841(4):484-94
Biochimica et biophysica acta 2014 Apr 4;1841(4):484-94
Characterization of the platelet granule proteome: evidence of the presence of MHC1 in alpha-granules.
Zufferey A, Schvartz D, Nolli S, Reny JL, Sanchez JC, Fontana P
Journal of proteomics 2014 Apr 14;101:130-40
Journal of proteomics 2014 Apr 14;101:130-40
Characterization of the Toll-like receptor expression profile in human multiple myeloma cells.
Abdi J, Mutis T, Garssen J, Redegeld F
PloS one 2013;8(4):e60671
PloS one 2013;8(4):e60671
Expression of Toll-like receptor-9 is associated with poor progression-free survival in prostate cancer.
Väisänen MR, Jukkola-Vuorinen A, Vuopala KS, Selander KS, Vaarala MH
Oncology letters 2013 May;5(5):1659-1663
Oncology letters 2013 May;5(5):1659-1663
Expression of Toll-like receptor 9 in mouse and human lungs.
Schneberger D, Caldwell S, Kanthan R, Singh B
Journal of anatomy 2013 May;222(5):495-503
Journal of anatomy 2013 May;222(5):495-503
Expression of Toll-like receptors 2 and 9 in cells of dog jejunum and colon naturally infected with Leishmania infantum.
Figueiredo MM, Amorim IF, Pinto AJ, Barbosa VS, Pinheiro Lde J, Deoti B, Faria AM, Tafuri WL
BMC immunology 2013 May 14;14:22
BMC immunology 2013 May 14;14:22
Short DNA sequences and bacterial DNA induce esophageal, gastric, and colorectal cancer cell invasion.
Kauppila JH, Karttunen TJ, Saarnio J, Nyberg P, Salo T, Graves DE, Lehenkari PP, Selander KS
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2013 Jun;121(6):511-22
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2013 Jun;121(6):511-22
Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation.
Chauhan SK, Singh VV, Rai R, Rai M, Rai G
Journal of clinical immunology 2013 Jul;33(5):954-64
Journal of clinical immunology 2013 Jul;33(5):954-64
Identification of lineage relationships and novel markers of blood and skin human dendritic cells.
Harman AN, Bye CR, Nasr N, Sandgren KJ, Kim M, Mercier SK, Botting RA, Lewin SR, Cunningham AL, Cameron PU
Journal of immunology (Baltimore, Md. : 1950) 2013 Jan 1;190(1):66-79
Journal of immunology (Baltimore, Md. : 1950) 2013 Jan 1;190(1):66-79
Spontaneous production of immunoglobulin M in human epithelial cancer cells.
Hu F, Zhang L, Zheng J, Zhao L, Huang J, Shao W, Liao Q, Ma T, Geng L, Yin CC, Qiu X
PloS one 2012;7(12):e51423
PloS one 2012;7(12):e51423
TLR4 and TLR9 are induced in oral lichen planus.
Siponen M, Kauppila JH, Soini Y, Salo T
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2012 Nov;41(10):741-7
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2012 Nov;41(10):741-7
NK cell tolerance to TLR agonists mediated by regulatory T cells after polymicrobial sepsis.
Souza-Fonseca-Guimaraes F, Parlato M, Fitting C, Cavaillon JM, Adib-Conquy M
Journal of immunology (Baltimore, Md. : 1950) 2012 Jun 15;188(12):5850-8
Journal of immunology (Baltimore, Md. : 1950) 2012 Jun 15;188(12):5850-8
The circadian clock controls toll-like receptor 9-mediated innate and adaptive immunity.
Silver AC, Arjona A, Walker WE, Fikrig E
Immunity 2012 Feb 24;36(2):251-61
Immunity 2012 Feb 24;36(2):251-61
Campylobacter jejuni disrupts protective Toll-like receptor 9 signaling in colonic epithelial cells and increases the severity of dextran sulfate sodium-induced colitis in mice.
O'Hara JR, Feener TD, Fischer CD, Buret AG
Infection and immunity 2012 Apr;80(4):1563-71
Infection and immunity 2012 Apr;80(4):1563-71
Molecular chaperoning by glucose-regulated protein 170 in the extracellular milieu promotes macrophage-mediated pathogen sensing and innate immunity.
Zuo D, Yu X, Guo C, Yi H, Chen X, Conrad DH, Guo TL, Chen Z, Fisher PB, Subjeck JR, Wang XY
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2012 Apr;26(4):1493-505
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2012 Apr;26(4):1493-505
Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma.
Ronkainen H, Hirvikoski P, Kauppila S, Vuopala KS, Paavonen TK, Selander KS, Vaarala MH
Journal of experimental & clinical cancer research : CR 2011 Sep 19;30:84
Journal of experimental & clinical cancer research : CR 2011 Sep 19;30:84
Increased Toll-like receptor 9 expression indicates adverse prognosis in oesophageal adenocarcinoma.
Kauppila JH, Takala H, Selander KS, Lehenkari PP, Saarnio J, Karttunen TJ
Histopathology 2011 Oct;59(4):643-9
Histopathology 2011 Oct;59(4):643-9
Engagement of TLR2 reverses the suppressor function of conjunctiva CD4+CD25+ regulatory T cells and promotes herpes simplex virus epitope-specific CD4+CD25- effector T cell responses.
Dasgupta G, Chentoufi AA, You S, Falatoonzadeh P, Urbano LA, Akhtarmalik A, Nguyen K, Ablabutyan L, Nesburn AB, BenMohamed L
Investigative ophthalmology & visual science 2011 May 17;52(6):3321-33
Investigative ophthalmology & visual science 2011 May 17;52(6):3321-33
Expression of Toll-like receptors 2 and 4 is increased in peripheral blood and synovial fluid monocytes of patients with enthesitis-related arthritis subtype of juvenile idiopathic arthritis.
Myles A, Aggarwal A
Rheumatology (Oxford, England) 2011 Mar;50(3):481-8
Rheumatology (Oxford, England) 2011 Mar;50(3):481-8
Human papillomavirus deregulates the response of a cellular network comprising of chemotactic and proinflammatory genes.
Karim R, Meyers C, Backendorf C, Ludigs K, Offringa R, van Ommen GJ, Melief CJ, van der Burg SH, Boer JM
PloS one 2011 Mar 14;6(3):e17848
PloS one 2011 Mar 14;6(3):e17848
Direct measurement of the quantum wavefunction.
Lundeen JS, Sutherland B, Patel A, Stewart C, Bamber C
Nature 2011 Jun 8;474(7350):188-91
Nature 2011 Jun 8;474(7350):188-91
Expression of toll-like receptor 9 in lungs of pigs, dogs and cattle.
Schneberger D, Lewis D, Caldwell S, Singh B
International journal of experimental pathology 2011 Feb;92(1):1-7
International journal of experimental pathology 2011 Feb;92(1):1-7
Immunolocalization of pulmonary intravascular macrophages, TLR4, TLR9 and IL-8 in normal and Pasteurella multocida-infected lungs of water buffalo (Bubalus bubalis).
Sethi RS, Brar RS, Singh O, Singh B
Journal of comparative pathology 2011 Feb-Apr;144(2-3):135-44
Journal of comparative pathology 2011 Feb-Apr;144(2-3):135-44
EBV lytic-phase protein BGLF5 contributes to TLR9 downregulation during productive infection.
van Gent M, Griffin BD, Berkhoff EG, van Leeuwen D, Boer IG, Buisson M, Hartgers FC, Burmeister WP, Wiertz EJ, Ressing ME
Journal of immunology (Baltimore, Md. : 1950) 2011 Feb 1;186(3):1694-702
Journal of immunology (Baltimore, Md. : 1950) 2011 Feb 1;186(3):1694-702
TLR9-induced interferon β is associated with protection from gammaherpesvirus-induced exacerbation of lung fibrosis.
Luckhardt TR, Coomes SM, Trujillo G, Stoolman JS, Vannella KM, Bhan U, Wilke CA, Moore TA, Toews GB, Hogaboam C, Moore BB
Fibrogenesis & tissue repair 2011 Aug 2;4:18
Fibrogenesis & tissue repair 2011 Aug 2;4:18
TLR9 signaling failure renders Peyer's patch regulatory B cells unresponsive to stimulation with CpG oligodeoxynucleotides.
Booth JS, Arsenault R, Napper S, Griebel PJ, Potter AA, Babiuk LA, Mutwiri GK
Journal of innate immunity 2010;2(5):483-94
Journal of innate immunity 2010;2(5):483-94
CD14 is a coreceptor of Toll-like receptors 7 and 9.
Baumann CL, Aspalter IM, Sharif O, Pichlmair A, Blüml S, Grebien F, Bruckner M, Pasierbek P, Aumayr K, Planyavsky M, Bennett KL, Colinge J, Knapp S, Superti-Furga G
The Journal of experimental medicine 2010 Nov 22;207(12):2689-701
The Journal of experimental medicine 2010 Nov 22;207(12):2689-701
Nasolacrimal duct closure modulates ocular mucosal and systemic CD4(+) T-cell responses induced following topical ocular or intranasal immunization.
Chentoufi AA, Dasgupta G, Nesburn AB, Bettahi I, Binder NR, Choudhury ZS, Chamberlain WD, Wechsler SL, BenMohamed L
Clinical and vaccine immunology : CVI 2010 Mar;17(3):342-53
Clinical and vaccine immunology : CVI 2010 Mar;17(3):342-53
Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific.
Wu J, Meng Z, Jiang M, Zhang E, Trippler M, Broering R, Bucchi A, Krux F, Dittmer U, Yang D, Roggendorf M, Gerken G, Lu M, Schlaak JF
Immunology 2010 Mar;129(3):363-74
Immunology 2010 Mar;129(3):363-74
Protein kinase D1 is essential for the proinflammatory response induced by hypersensitivity pneumonitis-causing thermophilic actinomycetes Saccharopolyspora rectivirgula.
Kim YI, Park JE, Brand DD, Fitzpatrick EA, Yi AK
Journal of immunology (Baltimore, Md. : 1950) 2010 Mar 15;184(6):3145-56
Journal of immunology (Baltimore, Md. : 1950) 2010 Mar 15;184(6):3145-56
Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response.
Panda A, Qian F, Mohanty S, van Duin D, Newman FK, Zhang L, Chen S, Towle V, Belshe RB, Fikrig E, Allore HG, Montgomery RR, Shaw AC
Journal of immunology (Baltimore, Md. : 1950) 2010 Mar 1;184(5):2518-27
Journal of immunology (Baltimore, Md. : 1950) 2010 Mar 1;184(5):2518-27
Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors.
Väisänen MR, Väisänen T, Jukkola-Vuorinen A, Vuopala KS, Desmond R, Selander KS, Vaarala MH
The Prostate 2010 Jun 1;70(8):817-24
The Prostate 2010 Jun 1;70(8):817-24
Chicken TLR21 is an innate CpG DNA receptor distinct from mammalian TLR9.
Keestra AM, de Zoete MR, Bouwman LI, van Putten JP
Journal of immunology (Baltimore, Md. : 1950) 2010 Jul 1;185(1):460-7
Journal of immunology (Baltimore, Md. : 1950) 2010 Jul 1;185(1):460-7
Expression of Toll-like receptor 9 in renal podocytes in childhood-onset active and inactive lupus nephritis.
Machida H, Ito S, Hirose T, Takeshita F, Oshiro H, Nakamura T, Mori M, Inayama Y, Yan K, Kobayashi N, Yokota S
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2010 Aug;25(8):2530-537
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2010 Aug;25(8):2530-537
TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients.
Wang C, Cao S, Yan Y, Ying Q, Jiang T, Xu K, Wu A
BMC cancer 2010 Aug 10;10:415
BMC cancer 2010 Aug 10;10:415
Toll-like receptor-9 expression is inversely correlated with estrogen receptor status in breast cancer.
Jukkola-Vuorinen A, Rahko E, Vuopala KS, Desmond R, Lehenkari PP, Harris KW, Selander KS
Journal of innate immunity 2009;1(1):59-68
Journal of innate immunity 2009;1(1):59-68
Toll-like receptor expression in normal ovary and ovarian tumors.
Zhou M, McFarland-Mancini MM, Funk HM, Husseinzadeh N, Mounajjed T, Drew AF
Cancer immunology, immunotherapy : CII 2009 Sep;58(9):1375-85
Cancer immunology, immunotherapy : CII 2009 Sep;58(9):1375-85
Expression of toll-like receptor 9 in horse lungs.
Schneberger D, Caldwell S, Suri SS, Singh B
Anatomical record (Hoboken, N.J. : 2007) 2009 Jul;292(7):1068-77
Anatomical record (Hoboken, N.J. : 2007) 2009 Jul;292(7):1068-77
Role for plasmacytoid dendritic cells in the immune control of recurrent human herpes simplex virus infection.
Donaghy H, Bosnjak L, Harman AN, Marsden V, Tyring SK, Meng TC, Cunningham AL
Journal of virology 2009 Feb;83(4):1952-61
Journal of virology 2009 Feb;83(4):1952-61
Pro-osteogenic phenotype of human aortic valve interstitial cells is associated with higher levels of Toll-like receptors 2 and 4 and enhanced expression of bone morphogenetic protein 2.
Yang X, Fullerton DA, Su X, Ao L, Cleveland JC Jr, Meng X
Journal of the American College of Cardiology 2009 Feb 10;53(6):491-500
Journal of the American College of Cardiology 2009 Feb 10;53(6):491-500
Stimulation of iNOS expression and apoptosis resistance in B-cell chronic lymphocytic leukemia (B-CLL) cells through engagement of Toll-like receptor 7 (TLR-7) and NF-kappaB activation.
Hammadi A, Billard C, Faussat AM, Kolb JP
Nitric oxide : biology and chemistry 2008 Sep;19(2):138-45
Nitric oxide : biology and chemistry 2008 Sep;19(2):138-45
STAT3- and STAT5-dependent pathways competitively regulate the pan-differentiation of CD34pos cells into tumor-competent dendritic cells.
Cohen PA, Koski GK, Czerniecki BJ, Bunting KD, Fu XY, Wang Z, Zhang WJ, Carter CS, Awad M, Distel CA, Nagem H, Paustian CC, Johnson TD, Tisdale JF, Shu S
Blood 2008 Sep 1;112(5):1832-43
Blood 2008 Sep 1;112(5):1832-43
Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion.
Ilvesaro JM, Merrell MA, Li L, Wakchoure S, Graves D, Brooks S, Rahko E, Jukkola-Vuorinen A, Vuopala KS, Harris KW, Selander KS
Molecular cancer research : MCR 2008 Oct;6(10):1534-43
Molecular cancer research : MCR 2008 Oct;6(10):1534-43
TLR9 is expressed in idiopathic interstitial pneumonia and its activation promotes in vitro myofibroblast differentiation.
Meneghin A, Choi ES, Evanoff HL, Kunkel SL, Martinez FJ, Flaherty KR, Toews GB, Hogaboam CM
Histochemistry and cell biology 2008 Nov;130(5):979-92
Histochemistry and cell biology 2008 Nov;130(5):979-92
Identification of two subpopulations of purified human blood B cells, CD27- CD23+ and CD27high CD80+, that strongly express cell surface Toll-like receptor 9 and secrete high levels of interleukin-6.
Cognasse F, Hamzeh-Cognasse H, Lafarge S, Chavarin P, Pozzetto B, Richard Y, Garraud O
Immunology 2008 Nov;125(3):430-7
Immunology 2008 Nov;125(3):430-7
Expression of TLR9 within human glioblastoma.
Meng Y, Kujas M, Marie Y, Paris S, Thillet J, Delattre JY, Carpentier AF
Journal of neuro-oncology 2008 May;88(1):19-25
Journal of neuro-oncology 2008 May;88(1):19-25
Deoxynucleic acids from Cryptococcus neoformans activate myeloid dendritic cells via a TLR9-dependent pathway.
Nakamura K, Miyazato A, Xiao G, Hatta M, Inden K, Aoyagi T, Shiratori K, Takeda K, Akira S, Saijo S, Iwakura Y, Adachi Y, Ohno N, Suzuki K, Fujita J, Kaku M, Kawakami K
Journal of immunology (Baltimore, Md. : 1950) 2008 Mar 15;180(6):4067-74
Journal of immunology (Baltimore, Md. : 1950) 2008 Mar 15;180(6):4067-74
Deoxynucleic acids from Cryptococcus neoformans activate myeloid dendritic cells via a TLR9-dependent pathway.
Nakamura K, Miyazato A, Xiao G, Hatta M, Inden K, Aoyagi T, Shiratori K, Takeda K, Akira S, Saijo S, Iwakura Y, Adachi Y, Ohno N, Suzuki K, Fujita J, Kaku M, Kawakami K
Journal of immunology (Baltimore, Md. : 1950) 2008 Mar 15;180(6):4067-74
Journal of immunology (Baltimore, Md. : 1950) 2008 Mar 15;180(6):4067-74
Human lymphatic endothelial cells express multiple functional TLRs.
Pegu A, Qin S, Fallert Junecko BA, Nisato RE, Pepper MS, Reinhart TA
Journal of immunology (Baltimore, Md. : 1950) 2008 Mar 1;180(5):3399-405
Journal of immunology (Baltimore, Md. : 1950) 2008 Mar 1;180(5):3399-405
Human lymphatic endothelial cells express multiple functional TLRs.
Pegu A, Qin S, Fallert Junecko BA, Nisato RE, Pepper MS, Reinhart TA
Journal of immunology (Baltimore, Md. : 1950) 2008 Mar 1;180(5):3399-405
Journal of immunology (Baltimore, Md. : 1950) 2008 Mar 1;180(5):3399-405
Antibodies specific for human or murine Toll-like receptors detect canine leukocytes by flow cytometry.
Burgener IA, Jungi TW
Veterinary immunology and immunopathology 2008 Jul 15;124(1-2):184-91
Veterinary immunology and immunopathology 2008 Jul 15;124(1-2):184-91
Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus.
Nakano S, Morimoto S, Suzuki J, Nozawa K, Amano H, Tokano Y, Takasaki Y
Rheumatology (Oxford, England) 2008 Feb;47(2):145-9
Rheumatology (Oxford, England) 2008 Feb;47(2):145-9
The toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells.
Kundu SD, Lee C, Billips BK, Habermacher GM, Zhang Q, Liu V, Wong LY, Klumpp DJ, Thumbikat P
The Prostate 2008 Feb 1;68(2):223-9
The Prostate 2008 Feb 1;68(2):223-9
Localization of Toll-like receptors on epididymal epithelial cells and spermatozoa.
Palladino MA, Savarese MA, Chapman JL, Dughi MK, Plaska D
American journal of reproductive immunology (New York, N.Y. : 1989) 2008 Dec;60(6):541-55
American journal of reproductive immunology (New York, N.Y. : 1989) 2008 Dec;60(6):541-55
Inhibitors of TLR8 reduce TNF production from human rheumatoid synovial membrane cultures.
Sacre SM, Lo A, Gregory B, Simmonds RE, Williams L, Feldmann M, Brennan FM, Foxwell BM
Journal of immunology (Baltimore, Md. : 1950) 2008 Dec 1;181(11):8002-9
Journal of immunology (Baltimore, Md. : 1950) 2008 Dec 1;181(11):8002-9
Inhibitors of TLR8 reduce TNF production from human rheumatoid synovial membrane cultures.
Sacre SM, Lo A, Gregory B, Simmonds RE, Williams L, Feldmann M, Brennan FM, Foxwell BM
Journal of immunology (Baltimore, Md. : 1950) 2008 Dec 1;181(11):8002-9
Journal of immunology (Baltimore, Md. : 1950) 2008 Dec 1;181(11):8002-9
Induction of pro-inflammatory programs in enteroendocrine cells by the Toll-like receptor agonists flagellin and bacterial LPS.
Selleri S, Palazzo M, Deola S, Wang E, Balsari A, Marincola FM, Rumio C
International immunology 2008 Aug;20(8):961-70
International immunology 2008 Aug;20(8):961-70
Molecular cloning and characterization of equine Toll-like receptor 9.
Zhang YW, Davis EG, Blecha F, Wilkerson MJ
Veterinary immunology and immunopathology 2008 Aug 15;124(3-4):209-19
Veterinary immunology and immunopathology 2008 Aug 15;124(3-4):209-19
CD300a/c regulate type I interferon and TNF-alpha secretion by human plasmacytoid dendritic cells stimulated with TLR7 and TLR9 ligands.
Ju X, Zenke M, Hart DN, Clark GJ
Blood 2008 Aug 15;112(4):1184-94
Blood 2008 Aug 15;112(4):1184-94
Toll-like receptors in the uterus, cervix, and placenta: is pregnancy an immunosuppressed state?
Gonzalez JM, Xu H, Ofori E, Elovitz MA
American journal of obstetrics and gynecology 2007 Sep;197(3):296.e1-6
American journal of obstetrics and gynecology 2007 Sep;197(3):296.e1-6
Surface expression of Toll-like receptor 9 is upregulated on intestinal epithelial cells in response to pathogenic bacterial DNA.
Ewaschuk JB, Backer JL, Churchill TA, Obermeier F, Krause DO, Madsen KL
Infection and immunity 2007 May;75(5):2572-9
Infection and immunity 2007 May;75(5):2572-9
Nucleic acids exert a sequence-independent cooperative effect on sequence-dependent activation of Toll-like receptor 9.
Kindrachuk J, Potter JE, Brownlie R, Ficzycz AD, Griebel PJ, Mookherjee N, Mutwiri GK, Babiuk LA, Napper S
The Journal of biological chemistry 2007 May 11;282(19):13944-53
The Journal of biological chemistry 2007 May 11;282(19):13944-53
Members of the Toll-like receptor family of innate immunity pattern-recognition receptors are abundant in the male rat reproductive tract.
Palladino MA, Johnson TA, Gupta R, Chapman JL, Ojha P
Biology of reproduction 2007 Jun;76(6):958-64
Biology of reproduction 2007 Jun;76(6):958-64
Toll-like receptor 9 expression in murine and human adrenal glands and possible implications during inflammation.
Tran N, Koch A, Berkels R, Boehm O, Zacharowski PA, Baumgarten G, Knuefermann P, Schott M, Kanczkowski W, Bornstein SR, Lightman SL, Zacharowski K
The Journal of clinical endocrinology and metabolism 2007 Jul;92(7):2773-83
The Journal of clinical endocrinology and metabolism 2007 Jul;92(7):2773-83
Intracellular signaling mechanisms regulating toll-like receptor-mediated activation of eosinophils.
Wong CK, Cheung PF, Ip WK, Lam CW
American journal of respiratory cell and molecular biology 2007 Jul;37(1):85-96
American journal of respiratory cell and molecular biology 2007 Jul;37(1):85-96
Molecular characterization of coding sequences and analysis of Toll-like receptor 3 mRNA expression in water buffalo (Bubalus bubalis) and nilgai (Boselaphus tragocamelus).
Dhara A, Saini M, Das DK, Swarup D, Sharma B, Kumar S, Gupta PK
Immunogenetics 2007 Jan;59(1):69-76
Immunogenetics 2007 Jan;59(1):69-76
CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells.
Huggins J, Pellegrin T, Felgar RE, Wei C, Brown M, Zheng B, Milner EC, Bernstein SH, Sanz I, Zand MS
Blood 2007 Feb 15;109(4):1611-9
Blood 2007 Feb 15;109(4):1611-9
EBV latent membrane protein 2A induces autoreactive B cell activation and TLR hypersensitivity.
Wang H, Nicholas MW, Conway KL, Sen P, Diz R, Tisch RM, Clarke SH
Journal of immunology (Baltimore, Md. : 1950) 2006 Sep 1;177(5):2793-802
Journal of immunology (Baltimore, Md. : 1950) 2006 Sep 1;177(5):2793-802
EBV latent membrane protein 2A induces autoreactive B cell activation and TLR hypersensitivity.
Wang H, Nicholas MW, Conway KL, Sen P, Diz R, Tisch RM, Clarke SH
Journal of immunology (Baltimore, Md. : 1950) 2006 Sep 1;177(5):2793-802
Journal of immunology (Baltimore, Md. : 1950) 2006 Sep 1;177(5):2793-802
Toll-like receptor 9 (TLR9) is present in murine liver sinusoidal endothelial cells (LSECs) and mediates the effect of CpG-oligonucleotides.
Martin-Armas M, Simon-Santamaria J, Pettersen I, Moens U, Smedsrød B, Sveinbjørnsson B
Journal of hepatology 2006 May;44(5):939-46
Journal of hepatology 2006 May;44(5):939-46
Novel toll-like receptor 9 agonist induces epidermal growth factor receptor (EGFR) inhibition and synergistic antitumor activity with EGFR inhibitors.
Damiano V, Caputo R, Bianco R, D'Armiento FP, Leonardi A, De Placido S, Bianco AR, Agrawal S, Ciardiello F, Tortora G
Clinical cancer research : an official journal of the American Association for Cancer Research 2006 Jan 15;12(2):577-83
Clinical cancer research : an official journal of the American Association for Cancer Research 2006 Jan 15;12(2):577-83
The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9.
Tabeta K, Hoebe K, Janssen EM, Du X, Georgel P, Crozat K, Mudd S, Mann N, Sovath S, Goode J, Shamel L, Herskovits AA, Portnoy DA, Cooke M, Tarantino LM, Wiltshire T, Steinberg BE, Grinstein S, Beutler B
Nature immunology 2006 Feb;7(2):156-64
Nature immunology 2006 Feb;7(2):156-64
Activation of anti-hepatitis C virus responses via Toll-like receptor 7.
Lee J, Wu CC, Lee KJ, Chuang TH, Katakura K, Liu YT, Chan M, Tawatao R, Chung M, Shen C, Cottam HB, Lai MM, Raz E, Carson DA
Proceedings of the National Academy of Sciences of the United States of America 2006 Feb 7;103(6):1828-33
Proceedings of the National Academy of Sciences of the United States of America 2006 Feb 7;103(6):1828-33
Toll-like receptors in cellular subsets of human tonsil T cells: altered expression during recurrent tonsillitis.
Mansson A, Adner M, Cardell LO
Respiratory research 2006 Feb 27;7:36
Respiratory research 2006 Feb 27;7:36
Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome.
Gottenberg JE, Cagnard N, Lucchesi C, Letourneur F, Mistou S, Lazure T, Jacques S, Ba N, Ittah M, Lepajolec C, Labetoulle M, Ardizzone M, Sibilia J, Fournier C, Chiocchia G, Mariette X
Proceedings of the National Academy of Sciences of the United States of America 2006 Feb 21;103(8):2770-5
Proceedings of the National Academy of Sciences of the United States of America 2006 Feb 21;103(8):2770-5
Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells.
Lee J, Mo JH, Katakura K, Alkalay I, Rucker AN, Liu YT, Lee HK, Shen C, Cojocaru G, Shenouda S, Kagnoff M, Eckmann L, Ben-Neriah Y, Raz E
Nature cell biology 2006 Dec;8(12):1327-36
Nature cell biology 2006 Dec;8(12):1327-36
Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-alpha.
Niessner A, Sato K, Chaikof EL, Colmegna I, Goronzy JJ, Weyand CM
Circulation 2006 Dec 5;114(23):2482-9
Circulation 2006 Dec 5;114(23):2482-9
Deoxycytidyl-deoxyguanosine oligonucleotide classes A, B, and C induce distinct cytokine gene expression patterns in rhesus monkey peripheral blood mononuclear cells and distinct alpha interferon responses in TLR9-expressing rhesus monkey plasmacytoid dendritic cells.
Abel K, Wang Y, Fritts L, Sanchez E, Chung E, Fitzgerald-Bocarsly P, Krieg AM, Miller CJ
Clinical and diagnostic laboratory immunology 2005 May;12(5):606-21
Clinical and diagnostic laboratory immunology 2005 May;12(5):606-21
TGF-alpha regulates TLR expression and function on epidermal keratinocytes.
Miller LS, Sørensen OE, Liu PT, Jalian HR, Eshtiaghpour D, Behmanesh BE, Chung W, Starner TD, Kim J, Sieling PA, Ganz T, Modlin RL
Journal of immunology (Baltimore, Md. : 1950) 2005 May 15;174(10):6137-43
Journal of immunology (Baltimore, Md. : 1950) 2005 May 15;174(10):6137-43
TGF-alpha regulates TLR expression and function on epidermal keratinocytes.
Miller LS, Sørensen OE, Liu PT, Jalian HR, Eshtiaghpour D, Behmanesh BE, Chung W, Starner TD, Kim J, Sieling PA, Ganz T, Modlin RL
Journal of immunology (Baltimore, Md. : 1950) 2005 May 15;174(10):6137-43
Journal of immunology (Baltimore, Md. : 1950) 2005 May 15;174(10):6137-43
Expression of mRNA and proteins for toll-like receptors, associated molecules, defensins and LL-37 by SRIK-NKL, a CD8+ NK/T cell line.
Srivastava MD, Srivastava BI
Leukemia research 2005 Jul;29(7):813-20
Leukemia research 2005 Jul;29(7):813-20
Deviation from major codons in the Toll-like receptor genes is associated with low Toll-like receptor expression.
Zhong F, Cao W, Chan E, Tay PN, Cahya FF, Zhang H, Lu J
Immunology 2005 Jan;114(1):83-93
Immunology 2005 Jan;114(1):83-93
Human lung cancer cells express functionally active Toll-like receptor 9.
Droemann D, Albrecht D, Gerdes J, Ulmer AJ, Branscheid D, Vollmer E, Dalhoff K, Zabel P, Goldmann T
Respiratory research 2005 Jan 4;6:1
Respiratory research 2005 Jan 4;6:1
TLR-induced inflammation in cystic fibrosis and non-cystic fibrosis airway epithelial cells.
Greene CM, Carroll TP, Smith SG, Taggart CC, Devaney J, Griffin S, O'neill SJ, McElvaney NG
Journal of immunology (Baltimore, Md. : 1950) 2005 Feb 1;174(3):1638-46
Journal of immunology (Baltimore, Md. : 1950) 2005 Feb 1;174(3):1638-46
TLR-induced inflammation in cystic fibrosis and non-cystic fibrosis airway epithelial cells.
Greene CM, Carroll TP, Smith SG, Taggart CC, Devaney J, Griffin S, O'neill SJ, McElvaney NG
Journal of immunology (Baltimore, Md. : 1950) 2005 Feb 1;174(3):1638-46
Journal of immunology (Baltimore, Md. : 1950) 2005 Feb 1;174(3):1638-46
Evidence of Toll-like receptor molecules on human platelets.
Cognasse F, Hamzeh H, Chavarin P, Acquart S, Genin C, Garraud O
Immunology and cell biology 2005 Apr;83(2):196-8
Immunology and cell biology 2005 Apr;83(2):196-8
Cytoplasmic domain-mediated dimerizations of toll-like receptor 4 observed by beta-lactamase enzyme fragment complementation.
Lee HK, Dunzendorfer S, Tobias PS
The Journal of biological chemistry 2004 Mar 12;279(11):10564-74
The Journal of biological chemistry 2004 Mar 12;279(11):10564-74
CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides.
Gantner F, Hermann P, Nakashima K, Matsukawa S, Sakai K, Bacon KB
European journal of immunology 2003 Jun;33(6):1576-85
European journal of immunology 2003 Jun;33(6):1576-85
No comments: Submit comment
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Simple Western: TLR9 Antibody (26C593.2) [NBP2-24729] - Lane view shows a specific band for TLR9 in 0.5 mg/ml of Ramos lysate. This experiment was performed under reducing conditions using the 66-440 kDa separation system. Image using the Azide Free format of this antibody.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Simple Western: TLR9 Antibody (26C593.2) [NBP2-24729] - Lane view shows a specific band for TLR9 in 0.5 mg/ml of Ramos lysate. This experiment was performed under reducing conditions using the 66-440 kDa separation system. Image using the Azide Free format of this antibody.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Western Blot: TLR9 Antibody (26C593.2) [NBP2-24729] - Analysis of TLR9 in A) human PBMC, B) human intestine, C) mouse intestine, and D) rat intestine tissue lysates using this antibody at a dilution of 3 ug/ml.
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: TLR9 Antibody (26C593.2) [NBP2-24729] - Analysis using the Azide Free version of NBP2-24729. Staining of human spleen probed with TLR9 antibody at 5 ug/mL. Human tissue was used for this test. Staining of formalin-fixed tissues is enhanced by boiling tissue sections in 10 mM sodium citrate buffer, pH 6.0 for 10-20 min followed by cooling at RT for 20 min.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: TLR9 Antibody (26C593.2) [NBP2-24729] - Monkey retina tissue. Image from verified customer review.
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Flow Cytometry: TLR9 Antibody (26C593.2) [NBP2-24729] - Intracellular flow cytometric analysis of TLR9 FITC in human B cells using 1ug/10^6 cells of NBP2-24908. Cells were primarily stained with PE-conjugated CD19 antibody. Cells were then fixed and permeabilized and stained with 1ug of either isotype control
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Flow (Intracellular): TLR9 Antibody (26C593.2) [NBP2-24729] - Analysis using the PE conjugate of NBP2-24729. Staining of TLR9 in human PBMCs using 0.2 ug of this antibody. Shaded histogram represents cells without antibody; green represents a mouse IgG1-PE isotype control; red represents anti-TLR9 antibody.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Flow Cytometry: TLR9 Antibody (26C593.2) [NBP2-24729] - Analysis using the PE conjugate of NBP2-24729. Staining of TLR9 in Ramos cells using 0.1 ug of antibody. Shaded histogram represents Ramos cells without antibody; green represents a mouse IgG1-PE isotype control red represents anti-TLR9 antibody.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Flow Cytometry: TLR9 Antibody (26C593.2) [NBP2-24729] - Analysis using the Azide Free version of NBP2-24729. Staining of TLR9 in Ramos cells using 0.5 ug of this antibody. Shaded histogram represents Ramos cells without antibody; green represents isotype control; purple represents anti-TLR9 antibody.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Flow Cytometry: TLR9 Antibody (26C593.2) [NBP2-24729] - Analysis using the FITC conjugate of NBP2-24729. Staining of TLR9 in Ramos cells using 0.5 ug of this antibody. Green represents isotype control; red represents anti-TLR9 antibody. TLR intracellular flow kit was used for this test.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Flow Cytometry: TLR9 Antibody (26C593.2) [NBP2-24729] - Flow analysis of TLR9 in human PBMC using 0.5 ug of TLR9 antibody (red) and isotype control antibody (green).
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Flow Cytometry: TLR9 Antibody (26C593.2) [NBP2-24729] - Expression of TLR9 protein on epithelial cells. HNEC, Detroit-562 and FaDu were stained intracellularly with PE-Ab against TLR9 (open histograms) or appropriate isotype control (shaded histograms) and analyzed by flow cytometry. Representative pictures from one out of three independent experiments are shown. Image collected and cropped by CiteAb from the following publication (//dx.plos.org/10.1371/journal.pone.0098239), licensed under a CC-BY licence.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Flow Cytometry: TLR9 Antibody (26C593.2) [NBP2-24729] - Analysis of colonic LP or peritoneal cavity (PerC) of normal mice were evaluated by flow cytometry. B cells were intracellularly stained with the anti-TLR9 antibody after the cell surface staining with anti-B220 and CD5 antibodies, and examined using flow cytometry. N = 3, performed twice. Image collected and cropped by CiteAb from the following publication (//doi.org/10.1371/journal.pone.0146191) licensed under a CC-BY licence.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Flow Cytometry: TLR9 Antibody (26C593.2) [NBP2-24729] - Gating strategy for the detection of TLR-7 and -9 in B cell subsets. PBMC were isolated from whole blood and stained for surface markers before cells were fixed, permeabilised and stained for TLR-9. FSC and SSC were first used to gate out debris and SSC-A and SSC-H was utilized to eliminate duplicates. Further gating was done on CD45 and CD19, to target B cells. To separate between the different B cell populations, we gated on CD27 and IgD (D), followed by TLR-9 expression on these subsets. Data from one representative patient is shown. Image collected and cropped by CiteAb from the following publication (//doi.org/10.1371/journal.pone.0120383) licensed under a CC-BY licence.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Flow Cytometry: TLR9 Antibody (26C593.2) [NBP2-24729] - Expression of TLR9 on turbinate epithelial cells from healthy controls compared to turbinate and polyp epithelial cells from patients with CRSwNP, n = 5 (A). Intracellular staining for TLR9 (open histogram, black line) and isotype control (filled histogram) on turbinate epithelial cells from a healthy control (B), turbinate epithelial cells (C) and polyp epithelial cells from a patient (D), analysed using flow cytometry. Results are presented as mean +/- SEM, **P